Enclomiphene vs TRT: which should I consider first?

Short answer

• If you want future fertility or if testing suggests secondary (central) hypogonadism, try a fertility‑sparring approach first (enclomiphene/clomiphene or hCG).
• If you do not want children and you have primary testicular failure or need a predictable, rapid symptom response, testosterone replacement therapy (TRT) is reasonable first-line.
• Discuss options with an endocrinologist or urologist and get the right baseline labs before starting therapy.

Why (mechanisms and the practical implications)

• Enclomiphene / clomiphene (SERMs) and hCG: raise endogenous testosterone by increasing LH/FSH (or by directly replacing LH action with hCG). That preserves or can improve spermatogenesis, so these are preferred when fertility matters. Clomiphene (Clomid, generic clomiphene citrate) is commonly used off‑label for men. Enclomiphene (the single isomer) has been studied but is not widely approved or available in many countries. hCG (brands: Pregnyl, Novarel, Ovidrel/recombinant options) is another fertility‑sparing choice.
• TRT: provides exogenous testosterone (gels: AndroGel, Testim, Fortesta; injections: testosterone cypionate/enanthate — generic or Depo‑Testosterone in some markets; long‑acting injections: Aveed in the U.S. / Nebido in some countries; pellets: Testopel). It reliably relieves symptoms but suppresses gonadotropins and usually reduces sperm production, so it commonly causes infertility.

When each is preferred

• Try SERM/hCG first if:
  • You want to preserve or achieve fertility.
  • Labs show low testosterone with low/normal LH/FSH (secondary hypogonadism).
  • You want to stimulate your own testosterone production rather than take exogenous hormone.
• Consider TRT first if:
  • You have primary hypogonadism (low T with high LH/FSH indicating testicular failure).
  • You have significant symptomatic hypogonadism and do not want future fertility.
  • You prefer the simplicity/predictability of TRT and accept the fertility tradeoff.

Safety, monitoring, and downsides

• SERMs/hCG:
  • Pros: preserve fertility, raise endogenous T, oral (clomiphene) or injectable (hCG).
  • Cons: clomiphene/enclomiphene can cause visual changes, mood swings, hot flashes; enclomiphene specifically may be less available/approved depending on country. Efficacy varies.
  • Monitoring: T, LH/FSH, semen analysis if fertility is a goal, liver tests and symptom check.
• TRT:
  • Pros: predictable symptom relief, multiple formulations to match preference.
  • Cons: suppresses sperm, can cause erythrocytosis (monitor hematocrit), acne, fluid retention, possible effects on lipids and PSA; requires lifelong therapy if stopped symptoms return.
  • Monitoring: baseline and periodic morning total T, hematocrit, PSA (age appropriate), lipids/metabolic panel, and clinical follow‑up.

Practical next steps

1. Get proper baseline testing before any treatment: two morning total testosterone levels (on separate days), LH, FSH, prolactin, CBC, CMP, lipids, and PSA if appropriate. Consider SHBG/free T if needed.
2. If labs show secondary hypogonadism or you want fertility, discuss clomiphene (generic Clomid) or hCG with a specialist. Ask about availability of enclomiphene in your country—many clinicians use clomiphene because it’s readily accessible.
3. If labs show primary hypogonadism or you don’t want fertility, discuss TRT options (gels like AndroGel/Testim, injections, Aveed/Nebido where available, or pellets) and the monitoring plan.
4. If pituitary disease is suspected (very low T with abnormal prolactin or other pituitary symptoms), get endocrine imaging (MRI pituitary).

If you want, tell me:

• Your age, whether you want children in the future, and the most recent morning total testosterone, LH, and FSH values (if you have them). I can give a more specific recommendation and next‑step labs.